Kingsview Wealth Management »

Oncolytics Biotech shares owned by Kingsview Wealth Management

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Kingsview Wealth Management from 13F filings

Historical chart of Kingsview Wealth Management investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Kingsview Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Kingsview Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.6k 11k 0.87
2024-06-30 $11k 11k 0.99
2024-03-31 $12k 11k 1.06
2023-12-31 $15k 11k 1.35

More positions owned by Kingsview Wealth Management

Northern Lts Fd Tr Iv Monarch Procap I (MPRO)
Ishares Tr Core S&p Ttl Stk (ITOT)
Apple (AAPL)
Northern Lts Fd Tr Iv Monarch Blue Ch (MBCC)
NVIDIA Corporation (NVDA)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Northern Lts Fd Tr Iv Monarch Ambassad (MAMB)
Amazon (AMZN)
Northern Lts Fd Tr Iv Monarch Sel Subs (MSSS)
Oracle Corporation (ORCL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Northern Lts Fd Tr Iv Monarch Vol Fact (MVFG)
Innovator Etfs Trust Defined Wlt Shld (BALT)

View all positions for Kingsview Wealth Management

Top funds holding Oncolytics Biotech

Seeds Investor
International Assets Investment Management
Morgan Stanley
Goldman Sachs Group
Citadel Advisors
Royal Bank of Canada
Commonwealth Equity Services
CIBC World Markets
Geode Capital Management
Long Focus Capital Management
Virtu Financial
SeaCrest Wealth Management
Brave Asset Management
Newman Dignan & Sheerar
National Bank Of Canada /fi/

View all funds holding Oncolytics Biotech